Kimia Biosciences Board Approves Director Re-appointments & AGM Proposals

Kimia Biosciences Limited's Board of Directors met on September 3, 2026, approving several key appointments and proposals for the upcoming 33rd Annual General Meeting (AGM). The board re-appointed Mr. Sameer Goel as Director and appointed Mr. Amulya Kumar Nayak as Non-Executive Director. Ms. Reema Goyal and Mr. Avinash Prabhat were appointed as Non-Executive Independent Directors for five-year terms. The board also approved remuneration for cost auditors, took note of the cost audit report for FY25-26, and approved proposals to increase borrowing limits, create mortgages, and make loans/guarantees, all subject to member approval at the AGM. The notice for the 33rd AGM, scheduled for September 28, 2026, was also approved, along with the Board's Report and the 33rd Annual Report for FY25-26.